Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment

Pharmacogenetics and Genomics

Volumn 17, Issue 7, 2007, Pages 555-567

  Ohlendorff, Stine D ^a   Tofteng, Charlotte L ^a   Jensen, Jens Erik B ^a   Petersen, Solveig ^a   Civitelli, Roberto ^e   Fenger, Mogens ^a   Abrahamsen, Bo ^b   Hermann, Anne P ^c   Eiken, Pia ^d   Jrgensen, Niklas R ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c KOLDING HOSPITAL   (Denmark)

^d HILLERØD HOSPITAL   (Denmark)

^e WASHINGTON UNIVERSITY   (United States)

Author keywords

Fracture incidence; Hormone replacement therapy; Osteoclast; P2X7; Polymorphism; Purinergic

Indexed keywords

ADENOSINE TRIPHOSPHATE; ESTROGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; PURINE P2X6 RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DISEASE MARKER; ESTROGEN THERAPY; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; HORMONE SUBSTITUTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OSTEOCLAST; POSTMENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; VERTEBRA FRACTURE;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; BASE SEQUENCE; BONE DENSITY; DNA PRIMERS; ESTROGEN REPLACEMENT THERAPY; EXONS; FEMALE; FRACTURES, BONE; GENOTYPE; HAPLOTYPES; HUMANS; MIDDLE AGED; OSTEOCLASTS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PURINERGIC P2; RISK FACTORS; TIME FACTORS;

EID: 34250210564     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3280951625     Document Type: Article

References (37)

1. Ralston SH. Genetic determinants of susceptibility to osteoporosis. Curr Opin Pharmacol 2003; 3:286-290.
2. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 1996; 14:203-205.
3. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367:284-287.
4. Masi L, Becherini L, Gennari L, Colli E, Mansani R, Falchetti A, et al. Allelic variants of human calcitonin receptor: distribution and association with bone mass in postmenopausal Italian women. Biochem Biophys Res Commun 1998; 245:622-626.
5. Hosoi T, Miyao M, Inoue S, Hoshino S, Shiraki M, Orimo H, et al. Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcif Tissue Int 1999; 64:205-208.
6. Steinberg TH, Silverstein SC. Extracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line. J Biol Chem 1987; 262:3118-3122.
7. Steinberg TH, Newman AS, Swanson JA, Silverstein SC. ATP4-permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem 1987; 262:8884-8888.
8. 7 Receptors. J Biol Chem 2002; 277:7574-7580.
9. 2+ entry in rabbit osteoclasts. J Biol Chem 2001; 276:39107-39114.
10. Hoebertz A, Townsend-Nicholson A, Glass R, Burnstock G, Arnett TR. Expression of P2 receptors in bone and cultured bone cells. Bone 2000; 27:503-510.
11. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50:413-492.
12. 7 and inhibits osteoclast formation in RAWcells. Am J Physiol Cell Physiol 2004; 287:C403-C412.
13. 7 receptor by a subpopulation of human osteoblasts. J Bone Miner Res 2001; 16:846-856.
14. 7 receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcif Tissue Int 2003; 73:361-369.
15. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001; 276:125-132.
16. 7 receptors to activate NF-kappaB in osteoclasts. J Bone Miner Res 2004; 19:642-651.
17. 7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol 2003; 17:1356-1367.
18. 7 receptor. J Biol Chem 2001; 276:11135-11142.
19. 7 receptor. J Biol Chem 2003; 278:17108-17113.
20. 7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 2006; 281:2079-2086.
21. 7 receptor. J Biol Chem 2004; 279:31287-31295.
22. 7 gene in 1-2% of the Caucasian population. FEBS Lett 2005; 579:2675-2678.
23. 7 receptor of human leukemic lymphocytes. J Immunol 2005; 175:82-89.
24. 7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002; 359:1114-1119.
25. 7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J Immunol 2004; 172:3399-3405.
26. Mosekilde L, Hermann AP, Beck-Nielsen H, Charles P, Nielsen SP, Sorensen OH. The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 1999; 31:207-219.
27. Brzezinski A. Melatonin in humans. N Engl J Med 1997; 336:186-195.
28. Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H. Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone 1995; 16:385-390.
29. Mosekilde L, Beck-Nielsen H, Sorensen OH, Nielsen SP, Charles P, Vestergaard P, et al. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women-results of the Danish Osteoporosis Prevention Study. Maturitas 2000; 36:181-193.
30. Bodmer M, Fournel MA, Hinshaw LB. Preclinical review of anti-tumor necrosis factor monoclonal antibodies. Crit Care Med 1993; 21:S441-S446.
31. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76:887-893.
32. Excoffier L, Laval LG, Schneider S. Arlequin ver. 3.01: An integrated software package for population genetics. Evolutionary Bioinformatic On-line 2005; 1:47-50.
33. Weir BS. Genetic Data Analysis II. Sinauer Associates, Inc.; 1996.
34. Slatkin M, Excoffier L. Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity 1996; 76 (Pt 4):377-383.
35. 7 receptor does not affect its electrophysiological phenotype. Am J Physiol Cell Physiol 2003; 284:C749-C756.
36. 7 purinoceptor by 17beta-oestradiol. J Physiol 1998; 508 (Pt 3):659-666.
37. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003; 361:598-604.